Selected article for: "antibody detection and specific antibody detection"

Author: Dawson, Patrick; Malik, Mamunur Rahman; Parvez, Faruque; Morse, Stephen S.
Title: What Have We Learned About Middle East Respiratory Syndrome Coronavirus Emergence in Humans? A Systematic Literature Review
  • Document date: 2019_3_1
  • ID: yb54i1ne_95
    Snippet: A number of key gaps remain in epidemiology, including transmission, population-based incidence or prevalence rates, and geographic and demographic distributions of infections. Based on the limited human seroprevalence data so far, it seems likely that population prevalence is low, but the baseline should be established. It is also not clear whether seropositivity is a reliable indicator of prior infection. The finding of variable low antibody ti.....
    Document: A number of key gaps remain in epidemiology, including transmission, population-based incidence or prevalence rates, and geographic and demographic distributions of infections. Based on the limited human seroprevalence data so far, it seems likely that population prevalence is low, but the baseline should be established. It is also not clear whether seropositivity is a reliable indicator of prior infection. The finding of variable low antibody titers at 1 year postinfection indicates that methods other than traditional serosurveys may be required (Reusken et al. 2013a ). If serology is not reliable, this raises the question of how to screen populations. There are methods that are both more sensitive and more specific for antibody detection (Mishra et al. 2018) , as well as assays of cellular immunity (Zhao et al. 2017 ), but are costlier and more difficult for population screening.

    Search related documents:
    Co phrase search for related documents
    • antibody detection and epidemiology remain: 1
    • antibody detection and human seroprevalence: 1, 2
    • antibody detection and low antibody titer: 1
    • antibody detection and population prevalence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • antibody detection and population screening: 1, 2, 3, 4, 5, 6
    • antibody detection and prevalence rate: 1, 2, 3
    • antibody detection and prior infection: 1, 2, 3, 4, 5, 6, 7, 8
    • antibody titer and cellular immunity: 1, 2, 3, 4, 5, 6, 7, 8
    • antibody titer and low antibody titer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • antibody titer and population prevalence: 1, 2, 3
    • antibody titer and prevalence rate: 1, 2, 3
    • antibody titer and prior infection: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • baseline establish and population prevalence: 1
    • cellular immunity and population prevalence: 1
    • cellular immunity and prior infection: 1, 2